Source: PharmiWeb

ReNetx: ReNetX Bio Receives $7M Commitment from Wings for Life to Bring Spinal Cord Treatment to Trial

ReNetX Bio Receives $7M Commitment from Wings for Life to Bring Spinal Cord Treatment to TrialNEW HAVEN, Conn., Nov.

Read full article »
ReNetx's Competitors | ReNetx's News | ReNetx's Financials
Stay up-to-date with the latest news on ReNetx
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Erika R. Smith's photo - CEO of ReNetx

CEO

Erika R. Smith

CEO Approval Rating

75/100

Read more
Stay up-to-date with the latest news on ReNetx